2012
Proctor DM, Thompson CM, Suh M , Haws LC, Harris MA. 2012. Mode of action for intestinal carcinogenesis of ingested hexavalent chromium in mice. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: carcinogens , chromium , mode of action
Hays SM, Kirman C, Aylward L, Suh M , Proctor D. Gastric reduction of Cr(VI) in mice, rats and humans. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: chromium
Kirman CR, Hays SM, Aylward LL, Suh M , Proctor D. 2012. Physiologically-based pharmacokinetic model for mice, rats and humans orally-exposed to chromium. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: chromium , modeling , pharmacokinetics
Harris MA, Thompson CM, Wolf JC, Fedorov Y, Hixon JG, Proctor DM, Suh M , Haws LC. Assessment of genotoxic potential of Cr(VI) in the intestine via in vivo intestinal micronucleus assay and in vitro high content analysis in differentiated and undifferentiated caco-2. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: chromium , genotoxicity
Meddings J, Reichert H , Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.
Topics: Epidemiology , Pharmaceutics and Medical Devices
O’Brien TJ, Hao D, Suh M , Proctor D, Thompson CM, Harris MA, Parsons BL, Meyers MB. 2012. K-ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at the Society of Toxicology’s 51st Annual Meeting, March 11-15, San Francisco, CA.
View Abstract
Topics: chromium , water
Meddings J, Reichert H , Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.
Topics: Epidemiology , Pharmaceutics and Medical Devices
Meddings J, Reichert H , McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 Society of General Internal Medicine Annual Meeting, Orlando, FL, May 2012.
Topics: Epidemiology , Pharmaceutics and Medical Devices
Meddings J, Reichert H , Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: a necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 Society of General Internal Medicine Annual Meeting, Orlando, FL, May 2012.
Topics: Epidemiology , Pharmaceutics and Medical Devices
2011
Mitchell M , Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011
A Division of